Clinical Trial Details

Trial ID: L0441
Source ID: ChiCTR2000029144
Associated Drug: Danggui Shaoyao Powder
Title: Study for effect of classic prescription Danggui Shaoyao Powder in the treatment of Wet-stasis syndrome Non-alcoholic Fatty Liver Disease
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic fatty liver disease
Interventions: Experimental group:Danggui Shaoyao powder granule;Control group:Danggui Shaoyao powder granule simulant;
Outcome Measures: MRI-PDFF;serum activity of ALT;Abdominal Fibroscan CAP;weight;BMI;waistline;serum activity of AST;serum activity of GGT;serum levels of TC;fasting blood-glucose;fasting insulin;insulin resistance index;SF-36;TCM Syndrome Points;serum levels of TG;serum levels of HDL-C;serum levels of LDL;
Sponsor/Collaborators: Shuguang Hospital affiliated to Shanghai University of TCM
Gender: All
Age: 1865
Phases: Not applicable
Enrollment: Experimental group:56;Control group:56;
Study Type: Interventional study
Study Designs: Parallel
Start Date: 15/01/2020
Completion Date: --
Results First Posted: --
Last Update Posted: 20 January 2020
Locations: China
URL: http://www.chictr.org.cn/showproj.aspx?proj=48258